Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Slowing of progression of disease observed via MRI at 24 months Improvements…
Global Employee Engagement Drops for Only the Second Time in 12 Years, Costing the World’s Economy US$438 Billion
WASHINGTON, April 23, 2025 /PRNewswire/ -- For only the second time in the…
New Palm Beach Debuts with a 500+ Crore Pre-market Launch, Awakens Mumbai & Navi Mumbai Alike
The pre-market launch sales have tripled the annual primary micro-market absorption within…
Rio Tinto and AMG Metals & Materials to assess low-carbon aluminium project in India
LONDON, April 17, 2025 /PRNewswire/ -- Rio Tinto and AMG Metals &…
NOTICE OF PROPOSED SETTLEMENT AND SETTLEMENT APPROVAL HEARING
PROPOSED CLASS ACTION SETTLEMENT DID YOU ACQUIRE COMMON SHARES OF TREVALI MINING CORPORATION…
Improving’s Acquisition of InfraCloud Boosts Development Capabilities in Asia
DALLAS, April 15, 2025 /PRNewswire/ -- Improving, a modern digital services organization, has acquired…
IDEX Biometrics ASA: Mandatory notification of trades
IDEX Biometrics ASA informs of primary insider transactions as listed in the…
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
Multi-center clinical trial includes sites located in the US, UK and EU…
Pilgrim Secures 200 Crore Funding at 3,000 Crore pre-money Valuation
MUMBAI, India, March 18, 2025 /PRNewswire/ -- Pilgrim, a leading Indian clean…
Markel Group appoints Simon Wilson as Chief Executive Officer of Markel Insurance
RICHMOND, Va., March 17, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE: MKL)…